Concerning the treatment of thrombotic vascular disease, the following is/are true:
A. Aspirin is successful in preventing venous as arterial thromboembolism
B. Dipyridamole enhances the ability of aspirin to prevent arterial thrombosis
C. Ticlopidine is more effective than aspirin in patients with cerebrovascular disease
D. Ticlopidine prevents fibrinogen binding to the GPIIb-IIIa receptor complex
Answer:C
Concerning the treatment of thrombotic vascular disease, the following is/are true:
A. Aspirin is successful in preventing venous as arterial thromboembolism B. Dipyridamole enhances the ability of aspirin to prevent arterial thrombosis C. Ticlopidine is more effective than aspirin in patients with cerebrovascular disease D. Ticlopidine prevents fibrinogen binding to the GPIIb-IIIa receptor complex